We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01302730
Recruitment Status : Completed
First Posted : February 24, 2011
Last Update Posted : November 8, 2013
Sponsor:
Collaborators:
University of California, San Francisco
Oregon Health and Science University
Cedars-Sinai Medical Center
Information provided by (Responsible Party):
Eswar Krishnan, Stanford University

Brief Summary:
This study aims to test whether a new instrument (questionnaire) is useful for identifying patients with ankylosing spondylitis.

Condition or disease
Ankylosing Spondylitis Spondylarthritis

Study Type : Observational
Actual Enrollment : 490 participants
Time Perspective: Prospective
Official Title: A Self-Administered Questionnaire for Early Detection of Axial Spondyloarthritis
Study Start Date : April 2011
Primary Completion Date : March 2012
Study Completion Date : November 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Physician diagnosis of Ankylosing Spondylitis [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients referred to rheumatologist office will be potentially eligible.
Criteria

Inclusion Criteria:

  • Ability to provide informed consent

Exclusion Criteria:

  • Inability to provide informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01302730


Locations
United States, California
Stanford University
Stanford, California, United States, 94304
Sponsors and Collaborators
Stanford University
University of California, San Francisco
Oregon Health and Science University
Cedars-Sinai Medical Center
Investigators
Principal Investigator: Eswar Krishnan Stanford University

Responsible Party: Eswar Krishnan, ASSISTANT PROFESSOR, Stanford University
ClinicalTrials.gov Identifier: NCT01302730     History of Changes
Other Study ID Numbers: STANIRB-20278
First Posted: February 24, 2011    Key Record Dates
Last Update Posted: November 8, 2013
Last Verified: November 2013

Keywords provided by Eswar Krishnan, Stanford University:
ankylosing spondylitis
spondylarthritis
inflammatory back pain
seronegative

Additional relevant MeSH terms:
Spondylitis
Spondylitis, Ankylosing
Spondylarthritis
Bone Diseases, Infectious
Infection
Bone Diseases
Musculoskeletal Diseases
Spinal Diseases
Spondylarthropathies
Ankylosis
Joint Diseases
Arthritis